Antimicrobial Ointments and Methicillin-ResistantStaphylococcus aureusUSA300

Autor:	Tatsuya Hirayama, Satoshi Ichiyama, Hiroaki Yamamoto, Masakado Matsumoto, Etsuko Aoki, Masahiro Suzuki, Yoshitsugu Iinuma, Kazuhiro Yamada, Miki Nagao, Reiji Hiramatsu
Rok vydání:	2011
Předmět:	Microbiology (medical) Epidemiology ointments lcsh:Medicine Microbial Sensitivity Tests MRSA Bacitracin methicillin-resistant Staphylococcus aureus Biology medicine.disease_cause lcsh:Infectious and parasitic diseases Microbiology medicine Humans Usa300 clone lcsh:RC109-216 bacteria skin and connective tissue diseases over-the-counter drug resistance community acquired infections lcsh:R Dispatch neomycin nonprescription drugs polymyxin B USA300 antimicrobial drug resistant Neomycin biochemical phenomena metabolism and nutrition bacterial infections and mycoses Antimicrobial Methicillin-resistant Staphylococcus aureus Anti-Bacterial Agents stomatognathic diseases Infectious Diseases Staphylococcus aureus Polymyxin B medicine.drug
Zdroj:	Emerging Infectious Diseases, Vol 17, Iss 10, Pp 1917-1920 (2011) Emerging Infectious Diseases
ISSN:	1080-6059 1080-6040
DOI:	10.3201/eid1710.101365
Popis:	We tested 259 methicillin-resistant Staphylococcus aureus isolates and 2 USA300 ATCC type strains for susceptibility to bacitracin and neomycin contained in over-the-counter antibacterial ointments. Resistance to both bacitracin and neomycin was found only in USA300. The use of over-the counter antimicrobial drugs may select for the USA300 clone.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3970d121580fd5166a09ed3ff3815789 https://doi.org/10.3201/eid1710.101365 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.